Genitourinary Radiology: Page 14

Siemens readies new handheld ultrasound unit for ECR
By Erik L. Ridley
Handheld ultrasound systems represent a rapidly growing segment of the ultrasound market, and prospective purchasers will soon have an additional entrant to consider. Siemens Healthcare will unveil Acuson P500, a new handheld ultrasound platform, at this week's European Congress of Radiology (ECR) in Vienna.
March 1, 2015
2015 02 27 11 58 04 789 2015 03 02 Siemens P500 20150227185950
MRI-based prostate CAD shows high sensitivity for cancer
By Eric Barnes
An MRI-based prostate cancer computer-aided detection (CAD) system is scoring high marks for detecting intermediate-to-aggressive prostate cancers noninvasively, Dutch investigators have reported.
February 17, 2015
2015 02 17 12 14 24 990 2015 02 17 Prostate Cad Huisman Cad Validation Bottom 20150217191442
Risks on rise with transrectal ultrasound-guided biopsy
By AuntMinnieEurope.com staff writers
New research from Sweden shows that risks associated with transrectal ultrasound-guided biopsy are increasing, with men vulnerable to urinary tract infections and subsequent hospitalization, according to a study published online on 20 August in the Journal of Urology.
August 19, 2014
SNMMI: New PET tracer detects recurrent prostate cancer
By Wayne Forrest
German researchers have developed a new PET radiotracer that detects recurrent prostate cancer in patients with very low prostate-specific antigen levels, according to two preliminary studies presented this week at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in St. Louis.
June 11, 2014
2014 06 11 12 27 50 350 St Louis 200
SNMMI: SPECT/CT shines at sentinel lymph-node imaging
By AuntMinnieEurope.com staff writers
Presurgical SPECT/CT provides more effective sentinel node imaging than lymphoscintigraphy, according to results from an international multicenter trial presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 9, 2014
CADx helps characterize focal prostate lesions
By Erik L. Ridley
Thanks mostly to its ability to improve specificity, computer-aided diagnosis (CADx) software can bolster characterization of focal prostate lesions on multiparametric MRI scans, French researchers reported in the June issue of Radiology.
June 1, 2014
2013 12 02 13 51 11 718 French Flag Button 200
Start-up firm Blue Earth Diagnostics develops prostate PET agent
By Wayne Forrest
Researchers from GE Healthcare have set out on their own with Blue Earth Diagnostics, a start-up with plans to commercialize a PET radiopharmaceutical they hope will prove more useful than FDG for detecting and assessing recurrent prostate cancer.
May 4, 2014
2014 04 28 16 51 52 587 Facbc Prosta Scint Left 400 20140428235824
SIR: Prostate artery embolization proves useful
By Eric Barnes
An emerging treatment known as prostate artery embolization for benign prostatic hyperplasia is effective and long-lasting, without causing sexual dysfunction, according to a Portuguese study presented at the Society of Interventional Radiology (SIR) annual scientific meeting.
March 27, 2014
2013 08 12 11 53 24 72 Portuguese Button 200
CAD offers helping hand in prostate MRI
By Erik L. Ridley
Computer-aided detection (CAD) software can make it easier for radiologists to interpret complicated prostate MRI studies using multiple pulse sequences, Italian researchers reported at ECR 2014 in Vienna.
March 16, 2014
2014 03 18 10 28 35 967 2014 03 18 Cad Mri Prostate 200
Tread cautiously with MR-guided prostate biopsies
By Philip Ward
VIENNA - MR-guided biopsies of the prostate should only be performed in select patients, and it's vital to keep aware of false-negative results. Also, an urgent need exists for robust multicenter trials of targeted biopsies of the prostate, ECR 2014 delegates learned during a Special Focus session on Saturday.
March 8, 2014
2014 03 06 11 26 36 325 200x200 Ecr 2014
AAA gets orphan drug status, buys private distributor
By AuntMinnieEurope.com staff writers
Advanced Accelerator Applications (AAA) has received orphan drug designation status for gallium-68 DOTATATE.
March 4, 2014
Doctors are not informing patients of overdiagnosis risk
By Kate Madden Yee
Patients are not being told about the possibility of overdiagnosis and overtreatment as a result of cancer screening programs, and many say they wouldn't start a screening program if the overdiagnosis rate is too high, according to a German survey of patients in the U.S.
October 27, 2013
2013 10 25 11 47 58 638 Breast Self Exam 200
Previous Page
Page 14 of 22
Next Page